To amend the Office of National Drug Control Policy Reauthorization Act of 2006 to modify the authority of the Office of National Drug Control Policy and the United States Anti-Doping Agency, and for other purposes.
Restoring Confidence to the World Anti-Doping Agency Act of 2022
This bill modifies the authority of the Office of National Drug Control Policy (ONDCP) and the United States Anti-Doping Agency (USADA) with respect to the World Anti-Doping Agency (WADA).
Specifically, the ONDCP, in conjunction with USADA, must
use all available tools to ensure that WADA maintains a proper conflict-of-interest policy and that independent athletes from the United States and other democratic countries, or representatives of such athletes, have voting positions on the Executive Committee and governing bodies of WADA; demonstrate leadership within the global community; have strict standards that work toward countering the state-sponsored doping system of the Russian Federation and other state-sponsored, systemic fraud through doping; and work collaboratively with democratic countries. The bill requires the United States to have at least one seat on the Executive Committee of WADA as a condition of its participation in WADA.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.